Navigation Links
Arthrosurface HemiCAP(R) Focal Knee Resurfacing Implant Receives FDA Approval to Move into Final Investigational Stage
Date:9/5/2008

FRANKLIN, Mass., Sept. 5 /PRNewswire/ -- Arthrosurface, Inc. (http://www.arthrosurface.com), the developer of less-invasive joint resurfacing systems, announced that it has received approval from the U.S. FDA to begin its pivotal investigation for its line of focal knee resurfacing implants. The FDA stated that "there are no outstanding safety concerns" with the device and granted Phase III initiation.

Arthrosurface has been evaluating the safety and efficacy of its HemiCAP(R) implants for focal femoral condyle defects under an ongoing U.S. FDA IDE investigation. "We are very pleased with our 2 year results in the feasibility study. Our data has demonstrated remarkable improvement in pain and function in a challenging middle-aged patient population," said Matthias R. Schurhoff, MD, Vice President of Clinical Operations and Scientific Affairs.

With the HemiCAP(R) knee implant, the company is targeting a subgroup of knee patients, typically between the ages of 40 and 60 years, who have focal condylar defects and are likely to undergo knee replacement surgery in the future. HemiCAP(R) resurfacing is intended to bridge the gap between biologic procedures and conventional joint replacement. Arthrosurface's minimally invasive resurfacing system allows for preservation of healthy tissue and joint structures by limiting treatment to localized defects using a shallow inlay implant that is matched to the patient's own unique joint surface anatomy. "Maintaining the overall joint integrity and avoiding early tissue loss through arthroplasty bone cuts may provide a significant benefit for patients in the long-term management of joint degeneration," commented Steven Ek, COO.

With this Phase III study approval, the company is moving one step closer to bringing this new treatment option to U.S. patients.

The HemiCAP(R) knee implant, which has been in clinical use outside the U.S. for over 4
'/>"/>

SOURCE Arthrosurface, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Cellvizio(R) Confocal Microscopy Improves ERCP Bile Duct Cancer Detection, According to New Study Presented at DDW
2. VivaScope(R) Confocal Imager May Eliminate Need for Routine Skin Biopsies for Dermatology Patients
3. JUVA Skin & Laser Center Introduces Affirm CO2 to New York City Laser Resurfacing Clients
4. Laser Resurfacing Produces Long-Term Results
5. DOT Therapy: Newest Breakthrough Technology in Laser Skin Resurfacing
6. DeepFX(TM) and ActiveFX(TM) Fractional Resurfacing Featured at Annual Meeting of The American Society Of Aesthetic Plastic Surgery
7. The DOT CO2 Fractional: The Next Step in Laser Skin Resurfacing
8. Keep Father Time From Marching On: New Laser Treatments Offer Gentle and Effective Skin Resurfacing in a Flash
9. Ascension Orthopedics Launches the TITAN(TM) Humeral Resurfacing Device World Wide
10. Frost & Sullivan Honors ConforMIS for Its Contribution to Personalized Care Through its Customized Implant Development Technologies
11. New implant device remotely monitors heart failure patients at Northwestern Memorial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... 05, 2015 Colorful packaging and marketing ... are best for health. But all it really takes ... look for, reports the March 2015 Harvard Health ... says Kathy McManus, director of the Department of Nutrition ... cereal that hits all the markers of good nutrition. ...
(Date:3/5/2015)... 05, 2015 Daily Greens™, an ... green-focused smoothie line, Half Pint that will debut ... Daily Greens’™ current offerings, Half Pint is crafted ... juices and other ingredients that are sourced locally ... added. To preserve nutrients and extend shelf life, ...
(Date:3/5/2015)... Considering egg freezing? Atlanta Center for ... an informational event on March 30, where ... families with egg freezing. , What: Egg Freezing Cocktail ... Atlanta, GA, Time: 5:30 - 7:30 PM, Date: Monday, ... here ! , In response to the growing ...
(Date:3/5/2015)... 2015 Dr. Jim Hu has been ... at NewYork-Presbyterian/Weill Cornell Medical Center and recruited as the ... Medical College. He assumed his new role on Feb. ... in the use of robotic and minimally invasive surgery ... Center, he will lead cutting-edge clinical and research efforts ...
(Date:3/5/2015)... NY (PRWEB) March 05, 2015 Hope For ... York Sporting Clay Shoot to be held at Beretta Shooting ... 15, 2015. All proceeds from the event will benefit Hope ... sense of self, restoring the family unit, and restoring hope ... event will honor our nation’s heroes through a day of ...
Breaking Medicine News(10 mins):Health News:Tips to Find the Healthiest Breakfast Cereals, From the March 2015 Harvard Health Letter 2Health News:Daily Greens™ Debuts Organic Cold-Pressed Smoothie Line for Kids Exclusively in Whole Foods Markets 2Health News:Daily Greens™ Debuts Organic Cold-Pressed Smoothie Line for Kids Exclusively in Whole Foods Markets 3Health News:Egg Freezing Seminar Allows Women to Pause the Biological Clock for Age, Social or Medical Reasons 2Health News:Egg Freezing Seminar Allows Women to Pause the Biological Clock for Age, Social or Medical Reasons 3Health News:Robotic Surgery Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 2Health News:Robotic Surgery Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 3Health News:Robotic Surgery Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 4Health News:Hope For The Warriors Announces New York Clay Shoot to Benefit Military Families 2
... of the molecular controls for calcium flow in heart ... gene therapy might some day replace mechanical-assist devices or ... failure. Harvard heart researcher Dr. Roger Hajjar said many ... in heart failure in the elderly. Specifically, Hajjar and ...
... According to researchers, Americans will probably have to depend ... biological attack this year Second-generation vaccines are in the ... anthrax vaccine that's ready to go, approved by the ... sole maker of the anthrax vaccine to resume shipping ...
... new breakthrough a cell in adults that can turn into ... it was thought that only embryonic stem cells could do ... now being made to turn the adult cells into tissues ... transplanted back into the patient.// ,Ihor Lemischka of ...
... treat nausea, and research at the University of Sydney ... studies have shown that the active ingredients in ginger ... ingredient of chilli peppers and capsicum, a known pain ... the body called the vanilloid receptor, which sits on ...
... in sperm motility could be an enticing target for a ... men or women to block the process of fertilization. The ... into the tails of spermatozoa. This influx of calicum triggers ... ,The CatSper ion channel is found only in a principal ...
... At the University of California, chemists have taken ... Peidong Yang, assistant professor of chemistry at the ... nanowire nonolaser shorter than the width of a ... ultraviolet nanolasers have generated great excitement in the ...
Cached Medicine News:Health News:Gene treatment maintains normal Heart Beat 2Health News:An effective pain killer, 2Health News:Limiting sperm motility for contraception 2Health News:Discovery of World’s smallest laser 2
(Date:3/5/2015)... Mar. 05, 2015 Research and Markets ... of the "Global Pharma US & EU ... Plays Major Role In Shaping Up Business for ... offering. Strategy Diversification Divested: Productivity ... Cash position- Will accelerate Next wave of targeted ...
(Date:3/5/2015)... HAMPTON, N.J. , March 5, 2015 ... MNK ), a leading global specialty biopharmaceutical company, and ... that they have entered into a definitive agreement under ... from a Madison Dearborn -led investor group in ... Subject to customary closing conditions, the parties expect ...
(Date:3/5/2015)... VIENNA , March 5, 2015 ... announce the new generation of OASIS *    ... with enhanced processing power will set a benchmark for ... overcome obstacles and prevent delays whilst optimizing workflow management ... quality, patient comfort and safety for imaging in Neurology, ...
Breaking Medicine Technology:Global Pharma US & EU Outlook 2015: First -In-Class Innovations and Cost Optimization Plays Major Role In Shaping Up Business for Large Cap Pharmaceutical Companies 2Global Pharma US & EU Outlook 2015: First -In-Class Innovations and Cost Optimization Plays Major Role In Shaping Up Business for Large Cap Pharmaceutical Companies 3Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 2Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 3Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 4Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 5Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 6Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 7Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 8Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 9Hitachi Medical Systems Europe Launches the New Generation of OASIS*- The World's Most Powerful Open High-Field 1.2T MRI - A New Level in Patient-Centric Care 2Hitachi Medical Systems Europe Launches the New Generation of OASIS*- The World's Most Powerful Open High-Field 1.2T MRI - A New Level in Patient-Centric Care 3
... 2012 /PRNewswire-Asia/ -- China Botanic Pharmaceutical Inc. (NYSE ... the "Company"), a developer, manufacturer and distributor of ... in China, today announced the results of its ... on Tuesday, April 10, 2012 (Beijing Standard Time)  ...
... (NYSE AMEX: IBIO ) announced that ... proteins and vaccine antigens in whole green plants has ... of palivizumab, a humanized monoclonal antibody that binds to ... inhibits viral entry into cells. Palivizumab is used to ...
Cached Medicine Technology:China Botanic Announces Results of Annual General Meeting 2iBio Announces Production of Biosimilar Palivizumab with its iBioLaunch™ Technology 2iBio Announces Production of Biosimilar Palivizumab with its iBioLaunch™ Technology 3
... Model V-1000 is a new addition to the ... This high performance pump can achieve an ultimate ... of 64 L/min. Applications For ... concentrators Distillation applications from lab size ...
... PTFE membrane vacuum pump designed to handle most ... for use with up to two rotary evaporators ... vacuum ovens, concentrators, gel dryers, and filtration apparatuses ... resistant to chemicals and heat load ...
... performance for all vacuum requirements. A 3 ... to suit all applications. The large, sideview ... proper oil levels at a glance. The ... work with all Thermo Savant SpeedVac concentrating ...
... deliver critical performance for all vacuum requirements. ... pump performance to suit all applications. The ... checking of proper oil levels at a ... designed to work with all Thermo Savant ...
Medicine Products: